Antihypertensive drugs and risk of COVID-19?
- PMID: 32222168
- PMCID: PMC7194728
- DOI: 10.1016/S2213-2600(20)30158-2
Antihypertensive drugs and risk of COVID-19?
Comment in
-
Antihypertensive drugs and risk of COVID-19?Lancet Respir Med. 2020 May;8(5):e29. doi: 10.1016/S2213-2600(20)30156-9. Epub 2020 Mar 26. Lancet Respir Med. 2020. PMID: 32222167 Free PMC article. No abstract available.
-
Antihypertensive drugs and risk of COVID-19? - Authors' reply.Lancet Respir Med. 2020 May;8(5):e32-e33. doi: 10.1016/S2213-2600(20)30159-4. Epub 2020 Mar 26. Lancet Respir Med. 2020. PMID: 32222169 Free PMC article. No abstract available.
Comment on
-
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?Lancet Respir Med. 2020 Apr;8(4):e21. doi: 10.1016/S2213-2600(20)30116-8. Epub 2020 Mar 11. Lancet Respir Med. 2020. PMID: 32171062 Free PMC article. No abstract available.
References
-
- Beeftink MM, van der Sande NG, Bots ML. Safety of temporary discontinuation of antihypertensive medication in patients with difficult-to-control hypertension. Hypertension. 2017;69:927–932. - PubMed
-
- Vaur L, Bobrie G, Dutrey-Dupagne C. Short-term effects of withdrawing angiotensin converting enzyme inhibitor therapy on home self-measured blood pressure in hypertensive patients. Am J Hypertens. 1998;11:165–173. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical